Vesalius Longevity Labs Inc.

Vesalius Longevity Labs is building a global leading peptide and longevity company and the first publicly traded platform dedicated to physician-prescribed peptide therapeutics.

Recent News

Vesalius Longevity Labs Commences Trading Today on the Canadian Securities Exchange Under the Symbol "VLAB"

British Columbia and Scottsdale, Arizona--(Newsfile Corp. - November 12, 2026) - Vesalius Longevity Labs Inc. (CSE: VLAB) ("Vesalius" or the "Company") is pleased to announce that it will commence trading on the Canadian Securities Exchange ("CSE") under the symbol "VLAB" today, November 12, 2026. "Today marks an important milestone for Vesalius Labs, and I want to sincerely thank our Board of Directors, our entire team, and our shareholders and stakeholders for their support and guidance...

2026-11-12 7:00 AM EST

Ready to Announce with Confidence?

Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us